|
1
|
Shields CJ, Tiret E and Winter DC;
International Rectal Carcinoid Study Group. Carcinoid tumors of the
rectum: a multi-institutional international collaboration. Ann
Surg. 252:750–755. 2010. View Article : Google Scholar
|
|
2
|
Yoon SN, Yu CS, Shin US, et al:
Clinicopathological characteristics of rectal carcinoids. Int J
Colorectal Dis. 25:1087–1092. 2010. View Article : Google Scholar
|
|
3
|
Mani S, Modlin IM, Ballantyne G, Ahlman H
and West B: Carcinoids of the rectum. J Am Coll Surg. 179:231–248.
1994.
|
|
4
|
Modlin IM, Lye KD and Kidd M: A 5-decade
analysis of 13,715 carcinoid tumors. Cancer. 97:934–959. 2003.
View Article : Google Scholar
|
|
5
|
Gerstle JT, Kauffman GL Jr and Koltun WA:
The incidence, management, and outcome of patients with
gastrointestinal carcinoids and second primary malignancies. J Am
Coll Surg. 180:427–432. 1995.
|
|
6
|
Landry CS, Brock G, Scoggins CR, et al: A
proposed staging system for rectal carcinoid tumors based on an
analysis of 4701 patients. Surgery. 144:460–466. 2008. View Article : Google Scholar
|
|
7
|
Konishi T, Watanabe T, Kishimoto J, Kotake
K, Muto T and Nagawa H; Japanese Society for Cancer of the Colon
and Rectum. Prognosis and risk factors of metastasis in colorectal
carcinoids: results of a nationwide registry over 15 years. Gut.
56:863–868. 2007.
|
|
8
|
Soga J: Early-stage carcinoids of the
gastrointestinal tract: an analysis of 1914 reported cases. Cancer.
103:1587–1595. 2005. View Article : Google Scholar
|
|
9
|
Fujimoto Y, Oya M, Kuroyanagi H, Ueno M,
Akiyoshi T, Yamaguchi T and Muto T: Lymph-node metastases in rectal
carcinoids. Langenbecks Arch Surg. 395:139–142. 2010. View Article : Google Scholar
|
|
10
|
Fahy BN, Tang LH, Klimstra D, Wong WD,
Guillem JG, Paty PB, Temple LK, Shia J and Weiser MR: Carcinoid of
the rectum risk stratification (CaRRs): a strategy for preoperative
outcome assessment. Ann Surg Oncol. 14:1735–1743. 2007. View Article : Google Scholar
|
|
11
|
Hassan MM, Phan A, Li D, Dagohoy CG, Leary
C and Yao JC: Risk factors associated with neuroendocrine tumors: A
U.S.-based case-control study. Int J Cancer. 123:867–873. 2008.
View Article : Google Scholar
|
|
12
|
Hemminki K and Li X: Incidence trends and
risk factors of carcinoid tumors: a nationwide epidemiologic study
from Sweden. Cancer. 92:2204–2210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naunheim KS, Zeitels J, Kaplan EL, et al:
Rectal carcinoid tumors - treatment and prognosis. Surgery.
94:670–676. 1983.PubMed/NCBI
|
|
14
|
Soga J: Carcinoids of the rectum: an
evaluation of 1271 reported cases. Surg Today. 27:112–119. 1997.
View Article : Google Scholar
|
|
15
|
Tichansky DS, Cagir B, Borrazzo E, et al:
Risk of second cancers in patients with colorectal carcinoids. Dis
Colon Rectum. 45:91–97. 2002. View Article : Google Scholar
|
|
16
|
Schneider C, Wittekind C and Köckerling F:
An unusual incidence of carcinoid tumors and secondary
malignancies. Chirurg. 66:607–611. 1995.(In German).
|
|
17
|
Li AF, Hsu CY, Li A, Tai LC, Liang WY, Li
WY, Tsay SH and Chen JY: A 35-year retrospective study of carcinoid
tumors in Taiwan: differences in distribution with a high
probability of associated second primary malignancies. Cancer.
112:274–283. 2008.
|
|
18
|
Oberg K: Expression of growth factors and
their receptors in neuroendocrine gut and pancreatic tumors, and
prognostic factors for survival. Ann NY Acad Sci. 733:46–55. 1994.
View Article : Google Scholar
|
|
19
|
Modlin IM, Kidd M, Latich I, et al:
Current status of gastrointestinal carcinoids. Gastroenterology.
128:1717–1751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramage JK, Ahmed A, Ardill J, et al; UK
and Ireland Neuroendocrine Tumour Society. Guidelines for the
management of gastroenteropancreatic neuroendocrine (including
carcinoid) tumours (NETs). Gut. 61:6–32. 2012. View Article : Google Scholar
|
|
21
|
Anthony LB, Strosberg JR, Klimstra DS, et
al; North American Neuroendocrine Tumor Society (NANETS). The
NANETS consensus guidelines for the diagnosis and management of
gastrointestinal neuroendocrine tumors (nets): well-differentiated
NETS of the distal colon and rectum. Pancreas. 39:767–774. 2010.
View Article : Google Scholar
|
|
22
|
Ramage JK, Goretzki PE, Manfredi R, et al;
Frascati Consensus Conference participants. Consensus guidelines
for the management of patients with digestive neuroendocrine
tumours: well-differentiated colon and rectum tumour/carcinoma.
Neuroendocrinology. 87:31–39. 2008. View Article : Google Scholar
|
|
23
|
Seow-Cheoen F and Ho J: Tiny carcinoids
may be malignant. Dis Colon Rectum. 36:309–310. 1993. View Article : Google Scholar
|
|
24
|
Kwaan MR, Goldberg JE and Bleday R: Rectal
carcinoid tumors: review of results after endoscopic and surgical
therapy. Arch Surg. 143:471–475. 2008. View Article : Google Scholar
|
|
25
|
Moore JR, Greenwell B, Nuckolls K, et al:
Neuroendocrine tumors of the rectum: a 10-year review of
management. Am Surg. 77:198–200. 2011.PubMed/NCBI
|
|
26
|
Koura AN, Giacco GG, Curley SA, et al:
Carcinoid tumors of the rectum: effect of size, histopathology, and
surgical treatment on metastasis free survival. Cancer.
79:1294–1298. 1997. View Article : Google Scholar
|
|
27
|
Sippel RS and Chen H: Carcinoid tumors.
Surg Oncol Clin N Am. 15:463–478. 2006. View Article : Google Scholar
|
